Navigation Links
ConvaTec Launches Hydrofiber(R) Technology Web Site
Date:7/22/2009

SKILLMAN, N.J., July 22 /PRNewswire/ -- ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced the launch of a new web site, www.Hydrofiber.com, demonstrating how the company's proprietary Hydrofiber(R) Technology is transforming wound care.

Designed for clinicians managing chronic and acute wounds, the web site illustrates the unique features and benefits of Hydrofiber(R) Technology with extensive video, data and commentary from research scientists within ConvaTec Wound Therapeutics. This transformational technology, unique to ConvaTec, powers the performance of advanced wound care products, including AQUACEL(R), AQUACEL(R) Ag and Versiva(R) XC(R) dressings, each developed for different wound management needs.

"Hydrofiber(R) Technology is the intelligent choice to meet the diverse wound care needs of clinicians and their individual patients," said Michael Steadman, President of ConvaTec Wound Therapeutics. "This exciting, new online resource shows how our high performance dressings not only help clinicians achieve better outcomes and improve the patient experience, but also contribute to cost control."

Wounds can have a significant impact on the costs of both chronic and acute care. For example, U.S. hospital stays for adults during which pressure ulcers were diagnosed increased by 79% from 1993 to 2006, and the cost of 2006 hospitalizations including a diagnosis of pressure ulcers totaled $11 billion.(1) In addition, surgical site infections have been estimated in an analysis of 2005 National Inpatient Sample data to generate $1.6 billion in excess costs to US hospitals per year.(2)

ConvaTec dressings with Hydrofiber(R) Technology gel on contact with fluid, providing clinicians and patients with substantial wound care benefits. This unique gelling action enables the dressings to lock in exudate and its harmful components(3-5a) and contour closely to the wound bed,(6a) in response to changing wound conditions. With the addition of ionic silver, AQUACEL(R) Ag dressing also provides "on demand" broad-spectrum antimicrobial activity, responding to increased bacterial load with increased silver ion availability.(7,8a,b)

Advanced Wound Dressings with Hydrofiber(R) Technology from ConvaTec

AQUACEL(R) and AQUACEL(R) Ag dressings are soft, absorbent non-woven wound dressings based on Hydrofiber(R) Technology. Indicated for a wide range of moderate-to-highly exuding chronic and acute wounds, AQUACEL(R) and AQUACEL(R) Ag dressings come in a variety of shapes, sizes and formats. AQUACEL(R) Ag dressing also provides the broad-spectrum antimicrobial properties of ionic silver, which kills a broad range of pathogens in the dressing, including MRSA and vancomycin-resistant enterococci (VRE).(7)

Versiva(R) XC(R) dressing provides all the benefits of Hydrofiber(R) Technology plus a waterproof backing that acts as a barrier against bacteria and viral pathogens, including HIV and Hepatitis.(c,d) The unique properties of Versiva(R) XC(R) dressing help progress wounds toward healing.(9,10) Indicated for use with moderately-to-highly exuding chronic and acute wounds, because it includes Hydrofiber(R) Technology, Versiva(R) XC(R) dressing is also the only dressing designed specifically to cover AQUACEL(R) and AQUACEL(R) Ag dressings.

ConvaTec dressings containing Hydrofiber(R) Technology have been evaluated in numerous clinical trials across a range of chronic and acute wounds, including pressure ulcers, leg ulcers, diabetic foot ulcers, partial thickness (second degree) burns and surgical incisions.

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions - Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices - ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. For more information, please visit www.convatec.com.

a. As demonstrated in vitro

b. The amount of silver released is controlled by the maximum concentration of silver that can enter solution.

c. provided the dressing remains intact and without leakage. The use of this dressing neither guarantees nor warrantees against AIDS or Hepatitis virus transmission.

d. use waterproof tape to secure the edges of non-adhesive dressing or dressings that have been cut across the central area

  1. Russo CA, Steiner C, Spector W. Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project Statistical Brief #64: Hospitalizations Related to Pressure Ulcers Among Adults 18 Years and Older, 2006. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb64.pdf. Accessed July 8, 2009.
  2. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009;37(5):387-397.
  3. Waring MJ, Parsons D. Physico-chemical characterisation of carboxymethylated spun cellulose fibres. Biomaterials. 2001;22:903-912.
  4. Walker M, Hobot JA, Newman GR, Bowler PG. Scanning electron microscopic examination of bacterial immobilisation in a carboxymethylcellulose (Aquacel) and alginate dressing. Biomaterials. 2003;24(5):883-890.
  5. Walker M, Bowler PG, Cochrane CA. In vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products. Ostomy Wound Manage. 2007;53(9):18-25.
  6. Jones SA, Bowler PG, Walker M. Antimicrobial activity of silver-containing dressings is influenced by dressing conformability with a wound surface. Wounds. 2005;17(9):263-270.
  7. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber(R) dressing. Wound Repair Regen. 2004;12(3):288-294.
  8. Bowler PG, Jones SA, Walker M, Parsons D. Microbicidal properties of a silver-containing Hydrofiber(R) dressing against a variety of burn wound pathogens. J Burn Care Rehabil. 2004;25(2):192-196.
  9. Vanscheidt W, Munter KC, Klovekorn W Vin F, Gauthier JP, Ukat A . A prospective study on the use of a non-adhesive gelling foam dressing on exuding leg ulcers. J Wound Care. 2007;16(6):261-265.
  10. Parish LC, Dryski M, Cadden S. Prospective clinical study of a new adhesive gelling foam dressing in pressure ulcers Int Wound J. 2008;5:60-67.

Hydrofiber, AQUACEL, Versiva and XC are registered trademarks of ConvaTec Inc.

(C) 2009 ConvaTec Inc.

AP-007919-US

    Contacts:

    Punnie Donohue
    ConvaTec
    Phone: (908) 904-2151
    Punnie.Donohue@convatec.com

    Courtney Judd
    Weber Shandwick
    Phone: (212) 445-8365
    cjudd@webershandwick.com


'/>"/>
SOURCE ConvaTec
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ConvaTec Launches New Programs to Support and Recognize WOC Nursing
2. Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier
3. ConvaTec Launches New AQUACEL(R) Ag Dressing with Strengthening Fiber
4. ConvaTec and HemCon Announce Co-Promotion Agreement
5. ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
6. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
7. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
8. ConvaTec Launches New Lifestyle Magazine for People With an Ostomy
9. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
10. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
11. Baxa Launches Enhanced Online Product Content
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... ... On May 24, the Congressional Budget Office (CBO) projected that the amended ... would result in 23 million Americans losing their health insurance by 2026 as compared ... Affordable Care Act (ACA). , “It is clear from the CBO analysis that ...
(Date:5/26/2017)... CA (PRWEB) , ... May 26, 2017 , ... Dr. ... is proud to announce a new, informational blog post on insurance options. If a ... checking insurance plans may help save time and money. Visiting an in-network provider for ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Cactus Jack: Against All Odds”: ... many others. “Cactus Jack: Against All Odds” is the creation of published author, ... Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter and Jane ...
(Date:5/24/2017)... , ... May 24, 2017 , ... Altec ... participation in nVerge 2017 – a one-day technology conference in San Diego, CA. ... solution, which allows users to fully utilize and enhance their Sage ERP solutions by ...
(Date:5/24/2017)... DC (PRWEB) , ... May 24, 2017 , ... ... Center for Global Policy Solutions is vehemently opposed to Donald Trump’s budget, “A ... formula for despair that inspires fear, demonizes the poor, marginalizes underserved populations, undermines ...
Breaking Medicine News(10 mins):
(Date:5/6/2017)... , May 5, 2017   Provista , a ... more than 200,000 customers, today announced Jim Cunniff ... wealth of executive and business experience to Provista, including most ... pharmacy in California . He assumed his ... "Jim is a great fit for Provista," says Jody ...
(Date:5/4/2017)... , May 4, 2017  A recent ... Control, Ultraviolet-C light as a means ... SmartUVC,s ability to reduce bioburden on anesthesia workstations. ... reduction on high-touch, complex medical equipment surfaces contaminated ... infections. "This study further validates the ...
(Date:5/4/2017)... WAYNE, Pa. , May 4, 2017 /PRNewswire/ ... made from thermoplastics and other highly-engineered materials, is ... Microextrusion tubing has been developed in recent ... neurovascular interventional therapies and surgical applications. More expensive ... used to produce microextrusion tubing due to their ...
Breaking Medicine Technology: